Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hasumi

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1993
[Treatment of stage III and IV ovarian cancer--is neoadjuvant chemotherapy effective?]Y Shimizu, K Hasumi
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1994
[Prognostic factors of endocervical type adenocarcinoma in uterine cervix]K Yokosuka, K Hasumi
Nihon Sanka Fujinka Gakkai Zasshi|October 1, 1993
[Treatment of advanced ovarian cancer--is residual tumor diameter less than 2cm optimal?]Y Shimizu, K Hasumi
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-gammaJ T Chen, K Hasumi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1995
[Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry]J T Chen, K Hasumi
Cancer|November 1, 1978
Clear cell carcinoma of the uterine endocervix with an in situ componentK Hasumi, R L Ehrmann
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Clinical study of 84 primary vulvar carcinomas]T Yamashiro, K Hasumi, K Masubuchi
Thrombosis Research|October 23, 1997
Enhancement of plasminogen binding and fibrinolysis by chloropeptin IK Tachikawa, K Hasumi, A Endo
The Journal of Antibiotics|May 20, 2000
Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structureW Hu, S Ohyama, K Hasumi
European Journal of Biochemistry|October 5, 1990
Two glyceraldehyde-3-phosphate dehydrogenase isozymes from the koningic acid (heptelidic acid) producer Trichoderma koningiiK Sakai, K Hasumi, A Endo
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1993
[Treatment of stage III and IV ovarian cancer--is neoadjuvant chemotherapy effective?]Y Shimizu, K Hasumi
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1994
[Prognostic factors of endocervical type adenocarcinoma in uterine cervix]K Yokosuka, K Hasumi
Nihon Sanka Fujinka Gakkai Zasshi|October 1, 1993
[Treatment of advanced ovarian cancer--is residual tumor diameter less than 2cm optimal?]Y Shimizu, K Hasumi
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-gammaJ T Chen, K Hasumi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1995
[Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry]J T Chen, K Hasumi
Cancer|November 1, 1978
Clear cell carcinoma of the uterine endocervix with an in situ componentK Hasumi, R L Ehrmann
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Clinical study of 84 primary vulvar carcinomas]T Yamashiro, K Hasumi, K Masubuchi
Thrombosis Research|October 23, 1997
Enhancement of plasminogen binding and fibrinolysis by chloropeptin IK Tachikawa, K Hasumi, A Endo
The Journal of Antibiotics|May 20, 2000
Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structureW Hu, S Ohyama, K Hasumi
European Journal of Biochemistry|October 5, 1990
Two glyceraldehyde-3-phosphate dehydrogenase isozymes from the koningic acid (heptelidic acid) producer Trichoderma koningiiK Sakai, K Hasumi, A Endo
Pageof 22